Literature DB >> 15088392

A new group of highly active analgesic of the morphinan family.

T G Tolstikova1, E E Shultz, M P Dolgikh, G A Tolstikov.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15088392     DOI: 10.1023/b:dobs.0000017117.36287.ce

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


× No keyword cloud information.
  5 in total

1.  Bimorphinans as highly selective, potent kappa opioid receptor antagonists.

Authors:  A S Portoghese; A W Lipkowski; A E Takemori
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

2.  [The effect of solvents on the activity of new morphinan series analgesics].

Authors:  T G Tolstikova; D N Lazareva; G A Tolstikov
Journal:  Dokl Akad Nauk       Date:  1995-07

3.  Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.

Authors:  P S Portoghese; M Sultana; A E Takemori
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

4.  Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.

Authors:  P S Portoghese; M Sultana; S T Moe; A E Takemori
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

5.  Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine.

Authors:  P S Portoghese; H Nagase; A E Takemori
Journal:  J Med Chem       Date:  1988-07       Impact factor: 7.446

  5 in total
  1 in total

1.  To the nature of the effect of glycosidic clathration of pharmacons.

Authors:  T G Tolstikova; A O Bryzgalov; I V Sorokina; A S Ratushnyak; T A Zapara; O G Simonova; G A Tolstikov
Journal:  Dokl Biol Sci       Date:  2007 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.